BR0013467A - Alcoóis de piperidina - Google Patents

Alcoóis de piperidina

Info

Publication number
BR0013467A
BR0013467A BR0013467-8A BR0013467A BR0013467A BR 0013467 A BR0013467 A BR 0013467A BR 0013467 A BR0013467 A BR 0013467A BR 0013467 A BR0013467 A BR 0013467A
Authority
BR
Brazil
Prior art keywords
disorders
disease
piperidine alcohols
ocd
bulimia
Prior art date
Application number
BR0013467-8A
Other languages
English (en)
Inventor
Helmut Pruecher
Henning Boettcher
Karl-August Ackermann
Rudolf Gottschlich
Hartmut Greiner
Juergen Harting
Gerd Bartoszyk
Christoph Seyfried
Christoph Van Amsterdam
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BR0013467A publication Critical patent/BR0013467A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Abstract

Patente de Invenção: "ALCOóIS DE PIPERIDINA". A invenção se refere aos compostos da fórmula (I), onde R^ 1^, R^ 2^ e A possuem os significados fornecidos na reivindicação 1, sendo antagonistas potentes de 5-HT~ 2A~ e apropriados para tratamento de psicoses, esquizofrenia, depressão, distúrbios neurológicos, distúrbios de memória, doença de Parkinson, esclerose lateral amiotrófica, doença de Alzheimer, doença de Huntington, distúrbios alimentares, tais como, bulimia, anorexia nervosa, síndrome pré-menstrual e/ou para influenciar positivamente distúrbios obsessivo-compulsivos (OCD).
BR0013467-8A 1999-08-21 2000-08-08 Alcoóis de piperidina BR0013467A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19939756A DE19939756A1 (de) 1999-08-21 1999-08-21 Piperidinalkohole
PCT/EP2000/007664 WO2001014332A1 (de) 1999-08-21 2000-08-08 Piperidinalkohole

Publications (1)

Publication Number Publication Date
BR0013467A true BR0013467A (pt) 2002-04-30

Family

ID=7919197

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0013467-8A BR0013467A (pt) 1999-08-21 2000-08-08 Alcoóis de piperidina

Country Status (22)

Country Link
US (1) US6756370B1 (pt)
EP (1) EP1202966B1 (pt)
JP (1) JP2003507455A (pt)
KR (1) KR20020027502A (pt)
CN (1) CN1170819C (pt)
AR (1) AR025333A1 (pt)
AT (1) ATE268757T1 (pt)
AU (1) AU760392B2 (pt)
BR (1) BR0013467A (pt)
CA (1) CA2382295A1 (pt)
CZ (1) CZ2002499A3 (pt)
DE (2) DE19939756A1 (pt)
DK (1) DK1202966T3 (pt)
ES (1) ES2220537T3 (pt)
HU (1) HUP0203406A2 (pt)
MX (1) MXPA02001750A (pt)
NO (1) NO20020827D0 (pt)
PL (1) PL353590A1 (pt)
PT (1) PT1202966E (pt)
SK (1) SK2192002A3 (pt)
WO (1) WO2001014332A1 (pt)
ZA (1) ZA200202291B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US7902679B2 (en) * 2001-03-05 2011-03-08 Megica Corporation Structure and manufacturing method of a chip scale package with low fabrication cost, fine pitch and high reliability solder bump
AU2003232805A1 (en) * 2002-05-24 2003-12-12 Carl-Fr. Coester Pharmaceutical active substance combination and the use thereof
SI1831159T1 (sl) * 2004-12-21 2010-04-30 Hoffmann La Roche Derivati tetralina in indana ter njune uporabe
CN101891672B (zh) * 2010-07-07 2012-07-11 天津大学 哌啶酮加氢反应液提纯哌啶醇产品的分离提纯方法及装置
US20120129834A1 (en) * 2010-09-17 2012-05-24 Buck Institute For Research On Aging Serotonin receptor antagonists for use in the treatment of huntington's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA864772B (en) * 1985-07-02 1987-02-25 Merrell Dow Pharma Novel chemical compounds
US5093341A (en) * 1987-12-17 1992-03-03 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine derivatives useful as antithrombolytic agents
AU652759B2 (en) * 1990-06-01 1994-09-08 Aventisub Ii Inc. (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)- 4-piperidinemethanol
PT626968E (pt) * 1992-02-13 2002-03-28 Merrell Pharma Inc Derivados de piperidinilo tiaciclicos
FR2696744B1 (fr) * 1992-10-12 1994-12-30 Logeais Labor Jacques Dérivés de 2-pyrrolidone, leur procédé de préparation et leurs applications en thérapeutique.
WO1997022583A1 (de) * 1995-12-20 1997-06-26 Eckhart Pein Neue 1-phenylalkyl/alkylen-4-(.alpha.-hydroxydiphenylmethyl)-piperidin derivate und ihre verwendung als serotonin antagonisten
GB9718712D0 (en) * 1997-09-03 1997-11-12 Merck Sharp & Dohme Theraputic Agents

Also Published As

Publication number Publication date
AU7508800A (en) 2001-03-19
MXPA02001750A (es) 2003-03-27
AR025333A1 (es) 2002-11-20
CN1371365A (zh) 2002-09-25
CN1170819C (zh) 2004-10-13
EP1202966A1 (de) 2002-05-08
CA2382295A1 (en) 2001-03-01
HUP0203406A2 (hu) 2003-02-28
US6756370B1 (en) 2004-06-29
DE19939756A1 (de) 2001-02-22
ATE268757T1 (de) 2004-06-15
PL353590A1 (en) 2003-12-01
KR20020027502A (ko) 2002-04-13
EP1202966B1 (de) 2004-06-09
DK1202966T3 (da) 2004-09-27
ZA200202291B (en) 2003-10-29
NO20020827L (no) 2002-02-20
NO20020827D0 (no) 2002-02-20
AU760392B2 (en) 2003-05-15
DE50006759D1 (de) 2004-07-15
JP2003507455A (ja) 2003-02-25
SK2192002A3 (en) 2002-06-04
CZ2002499A3 (cs) 2002-05-15
PT1202966E (pt) 2004-10-29
ES2220537T3 (es) 2004-12-16
WO2001014332A1 (de) 2001-03-01

Similar Documents

Publication Publication Date Title
BR0012607A (pt) Derivados de n- (indolcarbonil) piperazina
BR0107578A (pt) Derivados de piperidina e piperazina
MEP45308A (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
ATE334939T1 (de) Sole auf der basis von kieselsäure
GT200100160A (es) Derivados 4-fenil-piridina.
NO20063928L (no) Substituerte kinolinforbindelser
BRPI0409611A (pt) derivados de piperazina e uso dos mesmos para o tratamento de doenças neurológicas e psiquiátricas
BR0013467A (pt) Alcoóis de piperidina
WO2009093209A3 (ru) 2-AЛKИЛAMИHO-3-APИЛCУЛЬФOHИЛ-ЦИKЛOAЛKAHO [e ИЛИ d] ПИPAЗOЛO [1,5-a] ПИPИMИДИHЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-HT6 РЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
BR9816121A (pt) Derivados de amida e uréia como inibidores dereuptake de 5-ht e como ligantes de 5-ht1b/1d
BR0208741A (pt) Derivados de piperidina
ATE278721T1 (de) Organische verbindungen
BR0012575A (pt) Derivados de indol
DK1636239T3 (da) Indolderivater med en forbedret antipsykotisk aktivitet
BR0115708A (pt) Compostos derivados de benzotiofeno, seu processo de obten-ção e uso dos mesmos
PL1893589T3 (pl) PODSTAWIONE POCHODNE N-BENZO[D]IZOKSAZOL-3-ILOAMINY JAKO INHIBITORY RECEPTORÓW mGluR5, SEROTONINY (5-HT) I NORADRENALINY I ICH ZASTOSOWANIE DO WYTWARZANIA ŚRODKÓW LECZNICZYCH
BRPI0415661A (pt) uso de um composto, composição farmacêutica, e, composto
DE60312029D1 (de) Verfahren zur herstellung c-7 substituierter 5-androstene
GEP20074256B (en) Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing
ATE443707T1 (de) Isoxazolin-indol-derivate mit verbesserter antipsychotischer und anxiolytischer aktivität
BR0116774A (pt) Piperazinilcarbonilquinolinas e -isoquinilinas
BR0108501A (pt) Compostos de n-hidróxiformamidas substituìdos por piperidina e piperazina como agentes inibidores de metaloproteinase
DE60200135D1 (de) 4-(2-Pyridyl)piperazine als Agonisten des 5HT7 Rezeptors
BRPI0509582A (pt) compostos de tiazol-amina e respectivas composições farmacêuticas
DE60014658D1 (de) Organische polymere

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1927 DE 11/12/2007.